Menu
ncarol.com
  • Home
  • Business
  • Music
  • Health
  • Real Estate
  • Finance
  • Financial
  • Stock Market
  • Yacht Buyer
ncarol.com

Acmeware and Avo Partner to Bring Real-Time Data Integration to MEDITECH Customers
ncarol.com/10317744

Trending...
  • David Boland, Inc. Awarded $54.3M Construction Contract by U.S. Army Corps of Engineers, Savannah District
  • Scoop Social Co. Partners with Air Canada to Celebrate New Direct Flights to Milan with Custom Italian Piaggio Ape Gelato Carts
  • International Law Group Expands Emergency Immigration Consultations for Somali Minnesotans Amid ICE Actions
Acmeware
Through a new partnership, Acmeware will provide a FHIR-enabled integration layer that allows Avo to access MEDITECH clinical data in real time at the point of care.

MEDFIELD, Mass. - ncarol.com -- Acmeware, a MEDITECH Alliance Partner, announced a partnership with Avo (AvoMD), an AI platform for clinical copilots and a fellow MEDITECH Alliance Partner. Together, the organizations are enabling MEDITECH customers to seamlessly push and pull data between MEDITECH and Avo's AI-powered clinical tools. As part of this partnership, Acmeware will serve as a seamless data integration layer for Avo's AI suite within MEDITECH environments, delivering a standards-based API using the HL7® FHIR® data format.

Through Acmeware's FHIR-enabled API, Avo can securely access real-time clinical data from MEDITECH to power context-aware, evidence-based decision support at the point of care. The integration is designed to align with MEDITECH architecture and interoperability frameworks while minimizing implementation complexity for provider organizations with one simple install.

Early adopters of the Acmeware–Avo integration include Moab Regional Hospital, Emanate Health, and Holyoke Medical Center, all of which are leveraging the solution to streamline access to AI-generated insights and documentation directly within their MEDITECH systems.

AI capabilities that will be further enhanced with this real-time integration include: Avo's Chart Assist functionality for workflows like pre-charting, admissions, and discharge, Ask Avo, a smart EHR-search and AI consult with patient data awareness, and AI Scribe, with longitudinal patient context awareness and automatic note-pushing.

More on ncarol.com
  • God, Give Me Today Offers a Compassionate Faith-Centered Response to Anxiety and Depression
  • International Law Group Expands Emergency Immigration Consultations for Somali Minnesotans Amid ICE Actions
  • Premium Bail Bonds Proudly Sponsors BOFAB BBQ Team at the 2026 Lakeland Pigfest
  • UK Financial Ltd Receives Recognition In Platinum Crypto Academy's "Cryptonaire Weekly"
  • P-Wave Press Announces Pushing the Wave 2024 by L.A. Davenport

"This partnership reflects our focus on delivering production-grade interoperability using modern standards," said Joel Benware, President and CEO of Acmeware. "By exposing MEDITECH data through a robust FHIR-based API, we're giving healthcare organizations flexible, scalable options to connect Avo's AI-driven insights directly to MEDITECH."

The collaboration expands upon Avo's existing relationship with MEDITECH through its Alliance partnership, while offering customers additional integration paths powered by Acmeware's interoperability expertise. Acmeware's integration layer ensures reliable access to the required clinical context—including patient, encounter, and observation data—while maintaining performance, security, and compliance requirements.

"At Avo, we've partnered with over 30 MEDITECH customers to support clinical workflows with the latest and greatest in AI at the point of care," said Joongheum Park, MD, Chief Product & AI Officer at Avo. "Working with Acmeware allows us to extend the value of our AI tools within MEDITECH environments in ways that fit naturally into provider workflows."

The partnership supports healthcare organizations seeking to extend MEDITECH with external clinical decision support capabilities while adhering to interoperability best practices. Together, Acmeware and Avo aim to simplify integration, reduce maintenance overhead, and support clinically meaningful use of real-time data.

Why it matters

As healthcare organizations increasingly look to extend EHR functionality using third-party applications, standards-based integration has become critical. This partnership highlights how FHIR APIs can be used to deliver real-time clinical decision support in MEDITECH environments.

More on ncarol.com
  • Preston Dermatology & Skin Surgery Center Wins Gold and Bronze in Prestigious Annual DIAMOND Awards
  • David Boland, Inc. Awarded $54.3M Construction Contract by U.S. Army Corps of Engineers, Savannah District
  • "Phinge Unveil™" Coming to Las Vegas to Showcase Netverse Patented Verified App-less Platform, AI & Modular Hardware Including Developer Conferences
  • Elizabeth McLaughlin, Founder and CEO of Red Wagon Group, named 2026 Presidential Leadership Scholar
  • U.S. Congressional Candidate Peter Coe Verbica on America's Asymmetric Crisis

For more information about Acmeware, visit www.acmeware.com.

For more information about AvoMD, visit www.avomd.com.

2 / 2

About Acmeware

Acmeware, Inc. provides data integration, professional services, training, solutions, and custom software that assist clients in realizing the maximum benefit from their MEDITECH EHR. We are a service-oriented company working in partnership with our clients to leverage the latest technologies, transform disparate raw data to knowledge, and deliver valuable insight to healthcare organizations. Acmeware's dedicated focus on MEDITECH related services allows us to provide solutions that are innovative, efficient, accurate, and affordable. acmeware.com

About Avo

Avo is the future-proof AI platform used by healthcare organizations to improve care and operational outcomes in a way clinicians love. Avo's platform offers end-to-end EHR copilots that simplify everyday clinical tasks like documentation, charting, discharge planning, ordering and more. Avo supports every member of the care team by effortlessly incorporating guidelines, protocols, and patient data into the workflow and transforming them into actionable tools. At Avo, we believe in standardizing care with love, not alerts. Visit avomd.com to learn more.

Media Contact
Greg D'Abate, VP of Sales & Marketing, Acmeware
Shelly Sasson, VP of Marketing & Strategy, Avo
gldabate@acmeware.com


Source: Acmeware, Inc

Show All News | Report Violation

0 Comments
1000 characters max.

Latest on ncarol.com
  • Stout Industrial Technology Appoints Paul Bonnett as Chief Executive Officer
  • Revenue Optics Appoints Ljupco Icevski as Executive Advisor in Strategic Move to Accelerate Commercial Development
  • Waarom brand mentions in ChatGPT steeds belangrijker worden
  • Yunishigawa Onsen's Annual "Kamakura Festival" will be held January 30 – March 1, 2026
  • At Your Service Plumbing Named a 2025 Nextdoor Neighborhood Fave
  • Custom Home Builder Connecticut Valley Homes Wins 2025 Home of the Year from the Modular Home Builders Association
  • Scoop Social Co. Partners with Air Canada to Celebrate New Direct Flights to Milan with Custom Italian Piaggio Ape Gelato Carts
  • Breakout Phase for Public Company: New Partnerships, Zero Debt, and $20 Million Growth Capital Position Company for 2026 Acceleration
  • Japan's Patented "Hammock'n" Smartphone Band Targets Hand Fatigue From Long Phone Use
  • Reditus Group Introduces A New Empirical Model for Early-Stage B2B Growth
  • CCHR: Harvard Review Exposes Institutional Corruption in Global Mental Health
  • Goatimus Launches Dynamic Context: AI Prompt Engineering Gets Smarter
  • Global License Exclusive Secured for Emesyl OTC Nausea Relief, Expanding Multi-Product Growth Strategy for Caring Brands, Inc. (N A S D A Q: CABR)
  • RNHA Affirms Support for President Trump as Nation Marks Historic Victory for Freedom
  • American Laser Study Club Announces 2026 Kumar Patel Prize in Laser Surgery Recipients: Ann Bynum, DDS, and Boaz Man, DVM
  • Lineus Medical Completes UK Registration for SafeBreak® Vascular
  • Canyons & Chefs Announces Revamped Homepage
  • $140 to $145 Million in 2026 Projected and Profiled in New BD Deep Research Report on its Position in $57 Billion US Marine Industry; N Y S E: OTH
  • Really Cool Music Releases Its Fourth Single - "So Many Lost Years"
_catLbl0 _catLbl1

Popular on ncarol.com

  • Phinge CEO Ranked #1 Globally by Crunchbase for the Last Week, Will Be in Las Vegas Jan. 4-9, the Week of CES to Discuss Netverse & IPO Coming in 2026 - 144
  • "Micro-Studio": Why San Diegans are Swapping Crowded Gyms for Private, One-on-One Training at Sweat Society - 116
  • VDG Virtuoso Emerges as a New-Model Independent Industry Figure Blending Artist, Executive, and Infrastructure Builder - 106
  • Walmart $WMT and COSTCO.COM $COST Distribution as SonicShieldX™ Platform Sets the Stage for Accelerated Growth in 2026: AXIL Brands (N Y S E: AXIL) - 101
  • A Well-Fed World, Youth Climate Save and PAN International Launch PHRESH: A Global Directory of Plant-Based Hunger Relief Organizations
  • Documentary "Prescription for Violence: Psychiatry's Deadly Side Effects" Premieres, Exposes Link Between Psychiatric Drugs and Acts of Mass Violence
  • Kaltra Launches Next-Gen MCHEdesign With Full Integration Into MCHEselect — Instant Simulation & Seamless Microchannel Coil Workflow
  • CredHub and Real Property Management Join Forces to Empower Franchise Owners with Rental Payment Credit Reporting Solutions
  • Lick Personal Oils Introduces the Ultimate Valentine's Day Gift Collection for Romantic, Thoughtful Gifting
  • Record Revenue, Tax Tailwinds, and AI-Driven Scale: Why Off The Hook YS Inc. Is Emerging as a Standout in the $57 Billion U.S. Marine Market

Copyright © 2026 ncarol.com | Contact Us | Privacy Policy | Terms of Service | Contribute